Virginia Commonwealth University Life Sciences researchers have discovered a new mechanism the malaria parasite uses to enter human red blood cells, which could lead to the development of a vaccine cocktail to fight the mosquito-borne disease.
The Virginia Commonwealth University School of Medicine has received a $3 million National Institutes of Health grant to test a new intervention that could increase the rate of consent to solid organ donation.
As interest soars in the potential of nuclear power to produce electricity without greenhouse gases, Virginia Commonwealth University's School of Engineering is rapidly expanding its curriculum to provide the next generation of nuclear engineers.
Virginia Commonwealth University researchers have identified a gene that plays a key role in regulating liver cancer progression, a discovery that could one day lead to new targeted therapeutic strategies to fight the highly aggressive disease.
The College of William and Mary and Virginia Commonwealth University are collaborating to take advantage of the research and expertise of their environmental science programs.
The 2008 Virginia Commonwealth University Life Sciences survey shows that eight in 10 adults nationwide favor making genetic testing easily available to all who want it, and 54 percent say that the benefits of conducting genetic research outweigh the risks.
Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that is overexpressed in 90 percent of human cancers. The discovery could one day lead to an effective gene therapy for cancer.
Noel Bairey Merz, M.D., a nationally recognized authority on preventive cardiology and women's heart health, has taken the top honor in the inaugural Dr. Carolyn McCue Woman Cardiologist of the Year Award program, presented by the Virginia Commonwealth University Pauley Heart Center.
Three Virginia Commonwealth University epidemiologists are downplaying the value of mandatory universal nasal screening of patients for MRSA, arguing that proven, hospital-wide infection control practices can prevent more of the potentially fatal infections.
The National Cancer Institute has awarded two grants totaling more than $4.25 million to a Virginia Commonwealth University Massey Cancer Center researcher for two studies to examine delays and disparities in colon cancer diagnosis.
Virginia Commonwealth University Institute of Molecular Medicine researchers have discovered how a gene, melanoma differentiation associated gene-9/syntenin (mda-9/syntenin), interacts with an important signaling protein to promote metastasis in human melanoma cells, a discovery that could one day lead to the development of the next generation of anti-metastatic drugs for melanoma and other cancers.
An international research team studying sound production in deep-sea fishes has found that cusk-eels use several sets of muscles to produce sound that plays a prominent role in male mating calls.
Virginia Commonwealth University School of Medicine researchers have uncovered how sodium is able to control specific potassium ion channels in cells, according to new study findings published online this week in Nature Chemical Biology.
Researchers at the Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have published findings that implicate a new chemoprevention gene therapy (CGT) for preventing and treating pancreatic cancer, one of the most lethal and treatment-resistant forms of cancer.
Virginia Commonwealth University is part of an international research team that received a Wellcome Trust Foundation grant totaling more than $2.8 million to identify the genetic variants that have an impact on the risk for recurrent major depression.
Mergers and acquisitions destroy leadership continuity in target companies' top management teams for at least a decade following a deal, according to a Virginia Commonwealth University study published in the July/August issue of the Journal of Business Strategy.
Molecular and biochemical mechanism of action of unique cytokine gene found to induce potent bystander antitumor effects in animal models and in Phase I clinical trials identified. The findings may lead researchers to develop potential novel enhanced therapies to treat various forms of cancer.
Physician-researchers from the Virginia Commonwealth University Massey Cancer Center "“ home to one of the nation's leading cancer palliative care programs -- published a case study in today's issue of the Journal of the American Medical Association (JAMA) exploring the role of chemotherapy given in the last phases of life to cancer patients in the United States.
The Virginia Commonwealth University School of Medicine has received a competitive grant totaling nearly $6 million from the National Institutes of Health's National Institute on Child Health & Human Development to examine polycystic ovary syndrome, a disorder of the endocrine system that affects as many as 5 million women.
More and more U.S. college students are smoking tobacco using waterpipes "“ or hookahs "“ and it's becoming a growing public health issue, according to a new study led by a Virginia Commonwealth University researcher.
The Virginia Commonwealth University Massey Cancer Center will open a Phase I pancreatic cancer study later this year in conjunction with leading researchers from Israel, marking the first time cancer researchers at VCU have partnered with their counterparts in Israel.
George W. Vetrovec, M.D., chair of cardiology at the Virginia Commonwealth University Medical Center, known nationally for his study and treatment of coronary artery disease, says a new technique for treating blocked coronary arteries shows promise, but is best performed by experienced physicians.
Virginia Commonwealth University has an expert available for comment regarding the significance of fasting during Lent, food traditions and overindulgences during Mardi Gras, and the significance of Easter eggs and candy.
The VCU Life Sciences Survey is the first poll to reflect the discovery reported internationally in November that human skin cells can be used to create stem cells or their near equivalents.
Research in biology, chemistry and medicine intersects with the arts, business and world studies in the premiere issue of Across the Spectrum, www.spectrum.vcu.edu, a new online magazine showcasing the scope of Virginia Commonwealth University's nearly $230 million research program across both of its campuses.
Frontal crash tests in laboratories are strong predictors of passenger cars' safety on the road, though they fail to accurately project driver fatality risks for trucks, according to a recent Virginia Commonwealth University study.
Virginia Commonwealth University researchers have discovered a new mechanism to inhibit key enzymes that play a major role in clotting disorders, which could lead to novel therapies to treat clots in the lungs and those localized deep in the body in areas such as the legs.
The genes that play a role in illegal drug abuse are not entirely the same as those involved in dependence on legal substances like alcohol and nicotine, and caffeine addiction appears to be genetically independent of all the others, according to a study led by Virginia Commonwealth University researchers.
Researchers at the Virginia Commonwealth University Massey Cancer Center have identified the enzyme sphingosine kinase 2 as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer.
Virginia Commonwealth University researchers have identified the role of a key enzyme called CEH in reducing heart disease, paving the way for new target therapies to reduce plaques in the arteries and perhaps in the future, help predict a patient's susceptibility to heart disease.
Doctors taught empathy techniques by theater professors show improved bedside manner, according to a pilot study by a Virginia Commonwealth University research team.
As we develop, the company we keep may be increasingly influenced by our genes, according to a new study led by Virginia Commonwealth University researchers.
IUDs found to be safe and effective in women considered at high risk for sexually transmitted diseases and pregnancy. That population was previously considered not good candidates for the contraceptive device. Findings could lead to updated guidelines for physicians providing IUDs.
A research team has identified a new biological function for a soccer ball-shaped nanoparticle called a buckyball "“ the ability to block allergic response, setting the stage for the development of new therapies for allergy.
Virginia Commonwealth University Massey Cancer Center researchers have uncovered a new mechanism of action of the anti-cancer drug sorafenib, which could stimulate the development of novel regimens in which it is combined with other molecularly targeted agents for patients with blood cancers and solid tumors.
The use of peginterferon alone, or in combination with ribavirin, points to a cure for hepatitis C, the leading cause of cirrhosis, liver cancer and the need for liver transplant, a Virginia Commonwealth University researcher said today.
A team of medical experts led by a Virginia Commonwealth University anesthesiologist and a thoracic surgeon from the University of Kentucky has established a set of clinical guidelines to help physicians decrease the need for blood transfusions in high-risk patients during cardiac operations.
The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments.
Sen. Jim Webb, D-Va., will be the featured speaker at Virginia Commonwealth University's 2007 spring commencement ceremony.
The Center for the Study of Biological Complexity at Virginia Commonwealth University has augmented its high throughput genomics capabilities with the acquisition of two pieces of equipment that reduce the amount of time it takes to sequence a genome from years to weeks, and in some cases, days.
Virginia Commonwealth University researchers have decoded the genome of a bacteria normally present in the healthy human mouth that can cause a deadly heart infection if it enters the bloodstream.
Patients given prostate cancer information prior to their medical examinations participated more actively in decision making and were less likely to opt for screening tests, according to a Virginia Commonwealth University study released today.
Erectile dysfunction drugs may be better than nitroglycerin in protecting the heart from damage before and after a severe heart attack, Virginia Commonwealth University researchers report today.
Virginia Commonwealth University Massey Cancer Center researchers have identified an approach to enhance the activity of a new anti-cancer agent that has already shown impressive efficacy in the treatment of chronic myelogenous leukemia.
Researchers at Virginia Commonwealth University's Massey Cancer Center have created a new method to improve the antileukemic activity of a novel agent that triggers programmed cell death, a development that could lead to more effective strategies for fighting leukemia and other malignancies.
Medical teams "“ not individuals "“ are critical to the prevention of catheter-related bloodstream infections, as well as for the overall health, safety, and welfare of patients, according to an editorial by two Virginia Commonwealth University physicians published in today's issue of the New England Journal of Medicine.
Americans' support for stem cell research has declined slightly, reversing a three-year trend, but an overwhelming majority paradoxically supports the use of such cells in pursuit of treatment for themselves or family members, according to the sixth annual Virginia Commonwealth University Life Sciences Survey released Thursday.
Antibiotics are routinely prescribed unnecessarily for acute bronchitis, according to Virginia Commonwealth University findings published in today's issue of the New England Journal of Medicine.
Virginia Commonwealth University researchers have developed a unique anti-sickling agent that may one day be effective in treating sickle cell disease, a painful and debilitating genetic blood disorder that affects approximately 80,000 Americans.
Some patients who experience recurrent depression may benefit from long-term maintenance treatment with anti-depressant medication, according to a new study led by a Virginia Commonwealth University researcher.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right